The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Luckily for you, we at StockStory have no conflicts of interest - our sole job is to help you find genuinely promising companies. That said, here is one stock where Wall Street’s positive outlook is supported by strong fundamentals and two where analysts may be overlooking some important risks.
Two Stocks to Sell:
Akamai (AKAM)
Consensus Price Target: $159.30 (27.5% implied return)
With a massive distributed network spanning 4,100+ points of presence in nearly 130 countries, Akamai Technologies (NASDAQ: AKAM) provides a global distributed cloud platform that helps businesses deliver, secure, and optimize their digital experiences online.
Why Should You Sell AKAM?
- Customers had second thoughts about committing to its platform over the last year as its average billings growth of 6.8% underwhelmed
- Gross margin of 58.3% is way below its competitors, leaving less money to invest in areas like marketing and R&D
- Capital intensity will likely increase as its free cash flow margin is anticipated to drop by 25.3 percentage points over the next year
Akamai is trading at $124.95 per share, or 4.2x forward price-to-sales. If you’re considering AKAM for your portfolio, see our FREE research report to learn more.
Sinclair (SBGI)
Consensus Price Target: $17.71 (29.6% implied return)
With over 2,400 hours of local news produced weekly and 640 broadcast channels reaching millions of American homes, Sinclair (NASDAQ: SBGI) operates a network of 185 local television stations across 86 U.S. markets, producing news programming and distributing content from major networks.
Why Are We Out on SBGI?
- Products and services are facing significant end-market challenges during this cycle as sales have declined by 11.4% annually over the last five years
- Eroding returns on capital suggest its historical profit centers are aging
- 7× net-debt-to-EBITDA ratio makes lenders less willing to extend additional capital, potentially necessitating dilutive equity offerings
At $13.67 per share, Sinclair trades at 0.3x forward price-to-sales. Dive into our free research report to see why there are better opportunities than SBGI.
One Stock to Buy:
Alignment Healthcare (ALHC)
Consensus Price Target: $24.92 (15.2% implied return)
Founded in 2013 with a mission to transform healthcare for seniors, Alignment Healthcare (NASDAQ: ALHC) provides Medicare Advantage health plans for seniors with features like concierge services, transportation benefits, and technology-driven care coordination.
Why Will ALHC Beat the Market?
- Annual revenue growth of 45.4% over the last two years was superb and indicates its market share increased during this cycle
- Earnings per share grew by 28.5% annually over the last four years and trumped its peers
- Free cash flow margin jumped by 11 percentage points over the last five years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
Alignment Healthcare’s stock price of $21.63 implies a valuation ratio of 24.3x forward EV-to-EBITDA. Is now the time to initiate a position? Find out in our full research report, it’s free.
Stocks We Like Even More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
